Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guizhou Antai Pharmaceutical is a pharmaceutical company based in Anshun, Guizhou Province, China, specializing in the research, development, and production of Traditional Chinese Medicine (TCM) and ethnic Miao medicines. Established in 1994, the company has built a robust portfolio of products focusing on gynecological health, pediatrics, and respiratory ailments. Its manufacturing facilities are fully GMP-certified, enabling the production of various dosage forms such as capsules, granules, and tablets. The company is recognized for its integration of traditional herbal knowledge with modern pharmaceutical science, utilizing the unique botanical resources of the Guizhou region. Key commercial products include Fuke Zaizao Wan and Xiao'er Kechuan Ling, which are prominent in the domestic Chinese market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guizhou Antai Pharmaceutical.